- Dual, component formulation for broad microbial coverage
- Oral tablet for ease of administration
- Resistant to digestive processes
- Can be used as per the instructions of a medical practitioner
Product Overview
CBCLAV 625 is a combination antibiotic formulation prescribed by healthcare professionals after clinical evaluation to support effective bacterial management.
Amoxicillin provides the primary antibacterial action, while clavulanic acid enhances its effectiveness by preventing enzymatic degradation. This combination is commonly selected when bacteria show reduced sensitivity to amoxicillin alone.
Functional Description
The tablet dosage form ensures consistent delivery of the medication when taken orally. CBCLAV 625 is generally included in treatment protocols that require close monitoring of bacterial activity.
The selection and duration of therapy are determined by the doctor based on microbial susceptibility, clinical assessment, and the patient’s overall condition.
Usage Guidance
Use this medication strictly as directed by a qualified healthcare professional. Dosage and dosing schedules are individualized according to medical advice.
Always complete the prescribed course unless advised otherwise by the doctor.
Storage & Safety
- Store in a cool, dry place with adequate air circulation.
- Avoid exposure to humidity and excessive heat.
- Keep out of reach of children.
- Use only as prescribed by a doctor.
Disclaimer: This product information is provided for reference purposes only. Clinic Bee Pharma does not sell medicines directly to consumers. Use only as directed by a qualified healthcare professional.